LOIS GONZALEZ: Open Payments
NPI 1164536439 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 29 payments from 13 companies in 2025. Trend: 2023 $350 · 2024 $286 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| Alkermes, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Lundbeck LLC | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Corium, LLC | 5 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
Products named: REXULTI, INGREZZA, CAPLYTA, Auvelity, ARISTADA, Azstarys, Jornay PM, VRAYLAR.
Industry payments across FL — which companies pay providers there.
